Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ORIC Pharmaceuticals
Biotech
Pfizer boosts ORIC shares with multiple myeloma collaboration
ORIC Pharmaceuticals now has enough cash to run through H1 2025 thanks to a $25 million equity investment and a new clinical partnership from Pfizer.
Annalee Armstrong
Dec 22, 2022 11:20am
FDA shores up executive team with 2 hires—Chutes & Ladders
Jul 1, 2022 9:30am
ORIC pulls off $120M Wall Street debut, eclipsing $86M goal
Apr 24, 2020 9:30am
Financial volatility be damned: ORIC guns for $86M IPO
Mar 4, 2020 8:22am